<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7417167\results\search\disease\results.xml">
  <result pre="Clin ElectrophysiolJacc. Clinical Electrophysiology2405-500X2405-5018Published by Elsevier on behalf of the" exact="American" post="College of Cardiology Foundation pmcid: 7417167S2405-500X(20)30695-2 doi: 10.1016/j.jacep.2020.08.002 :"/>
  <result pre="of Cardiology Foundation pmcid: 7417167S2405-500X(20)30695-2 doi: 10.1016/j.jacep.2020.08.002 : State-of-the-Art Review" exact="Arrhythmias" post="and COVID-19A Review DherangeParinitaMBBSaLangJoshuaMDaQianPierreMBBS, PhDaOberfeldBlakeBSbSauerWilliam H.MDaKoplanBruceMDaTedrowUshaMD, MScaâˆ—[a], [b], âˆ—Address"/>
  <result pre="[b], âˆ—Address for correspondence: Dr. Usha Tedrow, Department of Clinical" exact="Cardiac" post="Electrophysiology, Brigham and Womenâ€™s Hospital and Harvard Medical School,"/>
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="(COVID-19) on arrhythmias continues to evolve as new data emerge." exact="Cardiac" post="arrhythmias are more common in critically ill COVID-19 patients."/>
  <result pre="mechanisms that could result in arrhythmogenesis among COVID-19 patients include" exact="hypoxia" post="caused by direct viral tissue involvement of lungs, myocarditis,"/>
  <result pre="in arrhythmogenesis among COVID-19 patients include hypoxia caused by direct" exact="viral" post="tissue involvement of lungs, myocarditis, abnormal host immune response,"/>
  <result pre="viral tissue involvement of lungs, myocarditis, abnormal host immune response," exact="myocardial ischemia," post="myocardial strain, electrolyte derangements, intravascular volume imbalances, and drug"/>
  <result pre="COVID therapy and provide special considerations for patients with inherited" exact="arrhythmia" post="syndromes. It is also crucial to minimize exposure to"/>
  <result pre="syndromes. It is also crucial to minimize exposure to COVID-19" exact="infection" post="by stratifying the need for intervention and using telemedicine."/>
  <result pre="stratifying the need for intervention and using telemedicine. As COVID-19" exact="infection" post="continues to prevail with a potential for future surges,"/>
  <result pre="required to better understand pathophysiology and to validate management strategies." exact="Central" post="Illustration Highlights â€¢Cardiac arrhythmias are more common in critically"/>
  <result pre="patients. â€¢Arrhythmias occur not only as a result of direct" exact="viral" post="effect, but also due to systemic illness and drug"/>
  <result pre="a result of direct viral effect, but also due to" exact="systemic" post="illness and drug interactions. â€¢Management strategies to minimize the"/>
  <result pre="to minimize the impact on arrhythmias and exposure to COVID-19" exact="infection" post="are imperative. â€¢More data are required to better understand"/>
  <result pre="and to validate management strategies. Key Words arrhythmias channelopathies COVID-19" exact="myocarditis" post="QT prolongation SARS-CoV-2 torsades de pointes Abbreviations and Acronyms"/>
  <result pre="torsades de pointes Abbreviations and Acronyms AAD, antiarrhythmic drug ARDS," exact="acute" post="respiratory distress syndrome BrS, Brugada syndrome COVID-19, coronavirus disease-2019"/>
  <result pre="de pointes Abbreviations and Acronyms AAD, antiarrhythmic drug ARDS, acute" exact="respiratory" post="distress syndrome BrS, Brugada syndrome COVID-19, coronavirus disease-2019 ICD,"/>
  <result pre="Abbreviations and Acronyms AAD, antiarrhythmic drug ARDS, acute respiratory distress" exact="syndrome" post="BrS, Brugada syndrome COVID-19, coronavirus disease-2019 ICD, implantable cardioverter-defibrillator"/>
  <result pre="Acronyms AAD, antiarrhythmic drug ARDS, acute respiratory distress syndrome BrS," exact="Brugada syndrome" post="COVID-19, coronavirus disease-2019 ICD, implantable cardioverter-defibrillator LQTS, long QT"/>
  <result pre="AAD, antiarrhythmic drug ARDS, acute respiratory distress syndrome BrS, Brugada" exact="syndrome" post="COVID-19, coronavirus disease-2019 ICD, implantable cardioverter-defibrillator LQTS, long QT"/>
  <result pre="BrS, Brugada syndrome COVID-19, coronavirus disease-2019 ICD, implantable cardioverter-defibrillator LQTS," exact="long QT syndrome" post="PPE, personal protective equipment SARS-CoV-2, severe acute respiratory syndrome-coronavirus-2"/>
  <result pre="syndrome COVID-19, coronavirus disease-2019 ICD, implantable cardioverter-defibrillator LQTS, long QT" exact="syndrome" post="PPE, personal protective equipment SARS-CoV-2, severe acute respiratory syndrome-coronavirus-2"/>
  <result pre="LQTS, long QT syndrome PPE, personal protective equipment SARS-CoV-2, severe" exact="acute" post="respiratory syndrome-coronavirus-2 TdP, torsades de pointes TTE, transthoracic echocardiography"/>
  <result pre="long QT syndrome PPE, personal protective equipment SARS-CoV-2, severe acute" exact="respiratory" post="syndrome-coronavirus-2 TdP, torsades de pointes TTE, transthoracic echocardiography Severe"/>
  <result pre="acute respiratory syndrome-coronavirus-2 TdP, torsades de pointes TTE, transthoracic echocardiography" exact="Severe" post="acute respiratory syndrome-coronavirus-2Â (SARS-CoV-2), which causes coronavirus disease-2019 (COVID-19),"/>
  <result pre="respiratory syndrome-coronavirus-2 TdP, torsades de pointes TTE, transthoracic echocardiography Severe" exact="acute" post="respiratory syndrome-coronavirus-2Â (SARS-CoV-2), which causes coronavirus disease-2019 (COVID-19), was"/>
  <result pre="syndrome-coronavirus-2 TdP, torsades de pointes TTE, transthoracic echocardiography Severe acute" exact="respiratory" post="syndrome-coronavirus-2Â (SARS-CoV-2), which causes coronavirus disease-2019 (COVID-19), was first"/>
  <result pre="efforts are underway to better define the epidemiology of the" exact="disease" post="(3). Although many cases remain asymptomatic, the most common"/>
  <result pre="and fatigue. A minority of patients experience complications such as" exact="acute" post="respiratory distress syndrome (ARDS) and other end organ damage"/>
  <result pre="fatigue. A minority of patients experience complications such as acute" exact="respiratory" post="distress syndrome (ARDS) and other end organ damage (4)."/>
  <result pre="minority of patients experience complications such as acute respiratory distress" exact="syndrome" post="(ARDS) and other end organ damage (4). Of particular"/>
  <result pre="for clinicians during this rapidly evolving crisis (Central Illustration )." exact="Central" post="Illustration Mechanism and Management Strategies of Arrhythmias in COVID-19"/>
  <result pre="(Central Illustration ). Central Illustration Mechanism and Management Strategies of" exact="Arrhythmias" post="in COVID-19 Data on Arrhythmia From Previous Epidemics and"/>
  <result pre="Mechanism and Management Strategies of Arrhythmias in COVID-19 Data on" exact="Arrhythmia" post="From Previous Epidemics and the Current COVID-19 Outbreak Because"/>
  <result pre="Epidemics and the Current COVID-19 Outbreak Because we currently have" exact="limited" post="data on the current SARS-CoV-2 outbreak, it is worthwhile"/>
  <result pre="previous historic coronavirus epidemics due to SARS-CoV and Middle Eastern" exact="respiratory" post="syndrome coronavirus. In a case series of 121 patients"/>
  <result pre="historic coronavirus epidemics due to SARS-CoV and Middle Eastern respiratory" exact="syndrome" post="coronavirus. In a case series of 121 patients diagnosed"/>
  <result pre="fever, and 14.9% were found to have bradycardia as a" exact="transient" post="event (8). Tachycardia was not further characterized into arrhythmias,"/>
  <result pre="were found to have bradycardia as a transient event (8)." exact="Tachycardia" post="was not further characterized into arrhythmias, although 1 patient"/>
  <result pre="characterized into arrhythmias, although 1 patient was found to have" exact="transient" post="atrial fibrillation. It was noted that the tachycardia persisted"/>
  <result pre="into arrhythmias, although 1 patient was found to have transient" exact="atrial fibrillation." post="It was noted that the tachycardia persisted in 40%"/>
  <result pre="a case series of 70 patients with laboratory-confirmed Middle Eastern" exact="respiratory" post="syndrome coronavirus in 2014 in Saudi Arabia, cardiac arrhythmias"/>
  <result pre="case series of 70 patients with laboratory-confirmed Middle Eastern respiratory" exact="syndrome" post="coronavirus in 2014 in Saudi Arabia, cardiac arrhythmias including"/>
  <result pre="arrhythmias, as both COVID-19 and influenza are believed to cause" exact="myocarditis" post="and arrhythmias (10). Influenza has been noted to cause"/>
  <result pre="arrhythmias (10). Influenza has been noted to cause various tachyarrhythmias," exact="heart" post="block, and ventricular fibrillation, though most haveÂ been presumed"/>
  <result pre="has been noted to cause various tachyarrhythmias, heart block, and" exact="ventricular fibrillation," post="though most haveÂ been presumed to be secondary to"/>
  <result pre="and ventricular fibrillation, though most haveÂ been presumed to be" exact="secondary" post="to myocarditis (11). In a survey-based study conducted by"/>
  <result pre="fibrillation, though most haveÂ been presumed to be secondary to" exact="myocarditis" post="(11). In a survey-based study conducted by Madjid etÂ"/>
  <result pre="influenza activity were reported more likely to have a ventricular" exact="arrhythmia" post="treated with shock and with antitachycardia pacing (12). Our"/>
  <result pre="(14). A low prevalence of arrhythmias is noted among clinically" exact="stable" post="COVID-19 patients in a single-day snapshot survey-based data (15)."/>
  <result pre="(6) reported an occurrence of 5.9% of sustained episodes of" exact="ventricular tachycardia" post="or ventricular fibrillation in 187 hospitalized COVID-19 patients. The"/>
  <result pre="occurrence of 5.9% of sustained episodes of ventricular tachycardia or" exact="ventricular fibrillation" post="in 187 hospitalized COVID-19 patients. The data on arrhythmia"/>
  <result pre="of 5.9% of sustained episodes of ventricular tachycardia or ventricular" exact="fibrillation" post="in 187 hospitalized COVID-19 patients. The data on arrhythmia"/>
  <result pre="ventricular fibrillation in 187 hospitalized COVID-19 patients. The data on" exact="arrhythmia" post="characterization in COVID-19 patients in the United States are"/>
  <result pre="described by several authors in the literature. A case of" exact="transient" post="complete heart block requiring cardiopulmonary resuscitation was reported in"/>
  <result pre="by several authors in the literature. A case of transient" exact="complete" post="heart block requiring cardiopulmonary resuscitation was reported in a"/>
  <result pre="several authors in the literature. A case of transient complete" exact="heart" post="block requiring cardiopulmonary resuscitation was reported in a patient"/>
  <result pre="reported in a patient with COVID-19 (18). Another case of" exact="transient" post="high-grade atrioventricular (AV) block was reported, which was thought"/>
  <result pre="which was thought to be as a result of subclinical" exact="myocarditis" post="(19). In a case series by He etÂ al."/>
  <result pre="of the 2 patients with COVID-19 was found to have" exact="transient" post="complete heart block along with temporary occurrence of S1Q3T3,"/>
  <result pre="the 2 patients with COVID-19 was found to have transient" exact="complete" post="heart block along with temporary occurrence of S1Q3T3, which"/>
  <result pre="2 patients with COVID-19 was found to have transient complete" exact="heart" post="block along with temporary occurrence of S1Q3T3, which suggests"/>
  <result pre="heart block along with temporary occurrence of S1Q3T3, which suggests" exact="transient" post="pulmonary artery hypertension secondary to ARDS. Along with cases"/>
  <result pre="block along with temporary occurrence of S1Q3T3, which suggests transient" exact="pulmonary" post="artery hypertension secondary to ARDS. Along with cases of"/>
  <result pre="with temporary occurrence of S1Q3T3, which suggests transient pulmonary artery" exact="hypertension" post="secondary to ARDS. Along with cases of bradyarrhythmias, tachyarrhythmias"/>
  <result pre="temporary occurrence of S1Q3T3, which suggests transient pulmonary artery hypertension" exact="secondary" post="to ARDS. Along with cases of bradyarrhythmias, tachyarrhythmias including"/>
  <result pre="secondary to ARDS. Along with cases of bradyarrhythmias, tachyarrhythmias including" exact="atrial fibrillation," post="atrial flutter, supraventricular tachycardias, as well as ventricular arrhythmias,"/>
  <result pre="ARDS. Along with cases of bradyarrhythmias, tachyarrhythmias including atrial fibrillation," exact="atrial flutter," post="supraventricular tachycardias, as well as ventricular arrhythmias, have been"/>
  <result pre="been reported in patients with COVID-19. A case of multifocal" exact="ventricular tachycardia" post="was preceded by electrocardiography (ECG) findings of ST-segment elevation"/>
  <result pre="elevation in a patient with COVID-19 (20). A case of" exact="acute" post="bilateral pulmonary embolism in a COVID-19 patient later developed"/>
  <result pre="in a patient with COVID-19 (20). A case of acute" exact="bilateral" post="pulmonary embolism in a COVID-19 patient later developed sustained"/>
  <result pre="a patient with COVID-19 (20). A case of acute bilateral" exact="pulmonary embolism" post="in a COVID-19 patient later developed sustained monomorphic ventricular"/>
  <result pre="pulmonary embolism in a COVID-19 patient later developed sustained monomorphic" exact="ventricular tachycardia" post="with syncope requiring cardioversion (21). Also, some of the"/>
  <result pre="a brief episode of supraventricular tachycardia (23). A case of" exact="atrial flutter" post="with 2:1 AV block was seen as the presenting"/>
  <result pre="supraventricular tachycardia (23). A case of atrial flutter with 2:1" exact="AV block" post="was seen as the presenting rhythm in a male"/>
  <result pre="cases of cardiac arrhythmias in COVID-19 infection, which include high-grade" exact="AV block," post="new onset atrial fibrillation, polymorphic ventricular tachycardia due to"/>
  <result pre="in COVID-19 infection, which include high-grade AV block, new onset" exact="atrial fibrillation," post="polymorphic ventricular tachycardia due to a ventricular premature contraction"/>
  <result pre="which include high-grade AV block, new onset atrial fibrillation, polymorphic" exact="ventricular tachycardia" post="due to a ventricular premature contraction causing a long-short"/>
  <result pre="new onset atrial fibrillation, polymorphic ventricular tachycardia due to a" exact="ventricular premature contraction" post="causing a long-short sequence, and cardiac arrest with pulseless"/>
  <result pre="to a ventricular premature contraction causing a long-short sequence, and" exact="cardiac arrest" post="with pulseless electrical activity (25). These manifestations suggest various"/>
  <result pre="patients with a pre-existing proclivity. In the setting of a" exact="viral infection," post="chronic cardiovascular diseases can become unstable due to increased"/>
  <result pre="a pre-existing proclivity. In the setting of a viral infection," exact="chronic" post="cardiovascular diseases can become unstable due to increased metabolic"/>
  <result pre="pre-existing proclivity. In the setting of a viral infection, chronic" exact="cardiovascular" post="diseases can become unstable due to increased metabolic demand"/>
  <result pre="damage and increased inflammatory response, could increase the risk of" exact="acute" post="coronary syndrome, heart failure, and cardiac arrhythmias (27,28). Arrhythmias"/>
  <result pre="inflammatory response, could increase the risk of acute coronary syndrome," exact="heart" post="failure, and cardiac arrhythmias (27,28). Arrhythmias in COVID-19 may"/>
  <result pre="of acute coronary syndrome, heart failure, and cardiac arrhythmias (27,28)." exact="Arrhythmias" post="in COVID-19 may result either primarily due to hypoxia"/>
  <result pre="(27,28). Arrhythmias in COVID-19 may result either primarily due to" exact="hypoxia" post="caused from direct viral tissue involvement of lungs, myocarditis,"/>
  <result pre="may result either primarily due to hypoxia caused from direct" exact="viral" post="tissue involvement of lungs, myocarditis, or abnormal host immune"/>
  <result pre="abnormal host immune response, or secondarily as a result of" exact="myocardial ischemia," post="myocardial strain due to pulmonary hypertension, electrolyte derangements, intravascular"/>
  <result pre="as a result of myocardial ischemia, myocardial strain due to" exact="pulmonary" post="hypertension, electrolyte derangements, intravascular volume imbalances, and drug side"/>
  <result pre="hypertension, electrolyte derangements, intravascular volume imbalances, and drug side effects." exact="Arrhythmias" post="are not merely due to the direct effect of"/>
  <result pre="COVID-19 infection, but rather are likely as a result ofÂ" exact="systemic" post="illness (29). The potential mechanisms of arrhythmia in COVID-19"/>
  <result pre="a result ofÂ systemic illness (29). The potential mechanisms of" exact="arrhythmia" post="in COVID-19 are outlined in FigureÂ 1 . FigureÂ"/>
  <result pre="outlined in FigureÂ 1 . FigureÂ 1 Potential Mechanisms of" exact="Arrhythmia" post="and COVID-19 The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus"/>
  <result pre="FigureÂ 1 Potential Mechanisms of Arrhythmia and COVID-19 The severe" exact="acute" post="respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus enters host cells, leading to"/>
  <result pre="1 Potential Mechanisms of Arrhythmia and COVID-19 The severe acute" exact="respiratory" post="syndrome-coronavirus-2 (SARS-CoV-2) virus enters host cells, leading to viral"/>
  <result pre="acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus enters host cells, leading to" exact="viral infection" post="and immune system activation and affecting the lungs, heart,"/>
  <result pre="respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus enters host cells, leading to viral" exact="infection" post="and immune system activation and affecting the lungs, heart,"/>
  <result pre="arrhythmias may be broadly mediated by hypoxia, myocarditis, myocardial strain," exact="myocardial ischemia," post="medication effects, intravascular volume imbalance, and electrolyte imbalance. ACE2Â"/>
  <result pre="and electrolyte imbalance. ACE2Â =Â angiotensin-converting enzyme 2; ARDSÂ =Â" exact="acute" post="respiratory distress syndrome; CYP450Â =Â cytochrome P450; DICÂ =Â"/>
  <result pre="electrolyte imbalance. ACE2Â =Â angiotensin-converting enzyme 2; ARDSÂ =Â acute" exact="respiratory" post="distress syndrome; CYP450Â =Â cytochrome P450; DICÂ =Â disseminated"/>
  <result pre="acute respiratory distress syndrome; CYP450Â =Â cytochrome P450; DICÂ =Â" exact="disseminated intravascular coagulation;" post="GIÂ =Â gastrointestinal; ILÂ =Â interleukin; mRNAÂ =Â messenger"/>
  <result pre="overlapping yet distinct stages. This includes stage 1, for early" exact="infection" post="with constitutional symptoms, and stage 2, in which there"/>
  <result pre="with constitutional symptoms, and stage 2, in which there is" exact="viral" post="entry and replication in the type II pneumocytes, causing"/>
  <result pre="in which there is viral entry and replication in the" exact="type II" post="pneumocytes, causing direct viral cytotoxicity and activation of inflammatory"/>
  <result pre="entry and replication in the type II pneumocytes, causing direct" exact="viral" post="cytotoxicity and activation of inflammatory immune response, leading to"/>
  <result pre="to a cytokine storm (10). Hypoxia caused due to direct" exact="viral" post="involvement in the lung tissue Acute respiratory failure as"/>
  <result pre="caused due to direct viral involvement in the lung tissue" exact="Acute" post="respiratory failure as a result of lung injury from"/>
  <result pre="due to direct viral involvement in the lung tissue Acute" exact="respiratory" post="failure as a result of lung injury from novel"/>
  <result pre="failure as a result of lung injury from novel coronavirus" exact="infection" post="can lead to hypoxia. Following from our understanding of"/>
  <result pre="understanding of hypoxia-induced cellular damage as it is rooted in" exact="myocardial ischemia" post="due to coronary occlusion, hypoxia can activate anaerobic glycolysis,"/>
  <result pre="of hypoxia-induced cellular damage as it is rooted in myocardial" exact="ischemia" post="due to coronary occlusion, hypoxia can activate anaerobic glycolysis,"/>
  <result pre="damage as it is rooted in myocardial ischemia due to" exact="coronary occlusion," post="hypoxia can activate anaerobic glycolysis, reducing intracellular pH and"/>
  <result pre="it is rooted in myocardial ischemia due to coronary occlusion," exact="hypoxia" post="can activate anaerobic glycolysis, reducing intracellular pH and thus"/>
  <result pre="can activate anaerobic glycolysis, reducing intracellular pH and thus increasing" exact="cytosolic" post="calcium levels. This, in turn, can facilitate early and"/>
  <result pre="of connexin 43 in the gap junctions (31). Myocarditis SARS-CoV-2" exact="myocarditis" post="has been reported several times in the literature so"/>
  <result pre="so far (32,33). The proposed mechanism for the pathophysiology of" exact="myocarditis" post="includes direct myocardial injury as a consequence of direct"/>
  <result pre="myocarditis includes direct myocardial injury as a consequence of direct" exact="viral" post="tissue involvement (34) or due to extrapulmonary migration of"/>
  <result pre="to adverse myocardial remodeling by its action on angiotensin II" exact="type 1" post="receptors (36). Intracellular presence of the virus also inhibits"/>
  <result pre="calcium-channel blocker bepridil seem to target this part of the" exact="viral" post="life cycle by accumulating in the late endosomes or"/>
  <result pre="of immune activation and myocardial injury (32). Myocarditis can cause" exact="arrhythmia" post="in the acute stage due to a direct cytopathic"/>
  <result pre="and myocardial injury (32). Myocarditis can cause arrhythmia in the" exact="acute" post="stage due to a direct cytopathic effect, causing electrical"/>
  <result pre="stage due to a direct cytopathic effect, causing electrical imbalance," exact="ischemia" post="from microvascular dysfunction, and gap junction dysfunction from impaired"/>
  <result pre="impairment, especially seen in patients with overlapping inflammatory channelopathies. In" exact="viral" post="myocarditis, host and viral factors can cause structural as"/>
  <result pre="patients with overlapping inflammatory channelopathies. In viral myocarditis, host and" exact="viral" post="factors can cause structural as well as electrophysiological remodeling,"/>
  <result pre="circus-type re-entry or phase 2 re-entry without an obstacle (38)." exact="Arrhythmia" post="can also be seen in the post-inflammatory stage, in"/>
  <result pre="etÂ al. (39) describe a case of COVID-19 presenting with" exact="cardiogenic shock" post="and new onset cardiomyopathy with echocardiography showing a dilated"/>
  <result pre="case of COVID-19 presenting with cardiogenic shock and new onset" exact="cardiomyopathy" post="with echocardiography showing a dilated left ventricle (LV), severe"/>
  <result pre="cardiogenic shock and new onset cardiomyopathy with echocardiography showing a" exact="dilated" post="left ventricle (LV), severe and diffuse LV hypokinesia (LV"/>
  <result pre="with echocardiography showing a dilated left ventricle (LV), severe and" exact="diffuse" post="LV hypokinesia (LV ejection fraction 34%), and coronary angiography"/>
  <result pre="coronaries. Endomyocardial biopsy demonstrated cytopathic interstitial inflammatory cells, but no" exact="viral" post="particles were observed in the myocyte. This observation suggests"/>
  <result pre="direct role in myocardial injury (40), cytokines including interleukin (IL)-6," exact="tumor" post="necrosis factor-Î±, and IL-1 can modulate the expression and"/>
  <result pre="cardiac channelopathies) and cause prolongation of ventricular action potential (41,42)." exact="Inflammatory" post="cytokines are a well-studied trigger for arrhythmia, especially in"/>
  <result pre="are a well-studied trigger for arrhythmia, especially in patients with" exact="long QT syndrome" post="(LQTS), due to overactivation of the cardiac sympathetic system"/>
  <result pre="well-studied trigger for arrhythmia, especially in patients with long QT" exact="syndrome" post="(LQTS), due to overactivation of the cardiac sympathetic system"/>
  <result pre="(CYP450), which increases the bioavailability of QT-prolonging drugs (45). Myocardial" exact="ischemia" post="Potential causes for myocardial ischemia are microvascular dysfunction and"/>
  <result pre="bioavailability of QT-prolonging drugs (45). Myocardial ischemia Potential causes for" exact="myocardial ischemia" post="are microvascular dysfunction and a hyperinflammatory state, leading to"/>
  <result pre="of QT-prolonging drugs (45). Myocardial ischemia Potential causes for myocardial" exact="ischemia" post="are microvascular dysfunction and a hyperinflammatory state, leading to"/>
  <result pre="atherosclerotic plaque, causing vasoconstriction due to dysregulation of the coronary" exact="vascular" post="endothelial function. In one study, microvascular dysfunction was found"/>
  <result pre="microvascular dysfunction was found to be in the form of" exact="disseminated intravascular coagulation" post="due to hyperinflammation and immune activation (46). IL-6 and"/>
  <result pre="coagulation due to hyperinflammation and immune activation (46). IL-6 and" exact="tumor" post="necrosis factor-Î± can both cause depletion of the coagulation"/>
  <result pre="cause depletion of the coagulation and fibrinolytic system, leading to" exact="bleeding" post="as well as thrombosis (47). The other postulated mechanism"/>
  <result pre="coagulation and fibrinolytic system, leading to bleeding as well as" exact="thrombosis" post="(47). The other postulated mechanism of microvascular dysfunction causing"/>
  <result pre="thrombosis (47). The other postulated mechanism of microvascular dysfunction causing" exact="myocardial ischemia" post="is via infection-mediated vasculitis. SARS-CoV-2 attaches to the ACE"/>
  <result pre="(47). The other postulated mechanism of microvascular dysfunction causing myocardial" exact="ischemia" post="is via infection-mediated vasculitis. SARS-CoV-2 attaches to the ACE"/>
  <result pre="are also expressed in arterial and venous endothelial cells (48)." exact="Vasculitis" post="can thus be triggered either as a result of"/>
  <result pre="Vasculitis can thus be triggered either as a result of" exact="hypersensitivity" post="reaction induced due to direct viral entry in the"/>
  <result pre="as a result of hypersensitivity reaction induced due to direct" exact="viral" post="entry in the myocardial endothelial cells or due to"/>
  <result pre="ST-segment elevation has also been reported in patients with COVID-19" exact="infection" post="(50). Cytokine surge and inflammatory mediators can also cause"/>
  <result pre="infection (50). Cytokine surge and inflammatory mediators can also cause" exact="acute" post="coronary syndrome due to activation of inflammatory cells within"/>
  <result pre="Cytokine surge and inflammatory mediators can also cause acute coronary" exact="syndrome" post="due to activation of inflammatory cells within a pre-existing"/>
  <result pre="as well as vasoconstriction due to dysregulation of the coronary" exact="vascular" post="endothelial function (51). Pathogen-associated molecular patterns are formed with"/>
  <result pre="vascular endothelial function (51). Pathogen-associated molecular patterns are formed with" exact="viral" post="products in the systemic circulation, which can cause activation"/>
  <result pre="Pathogen-associated molecular patterns are formed with viral products in the" exact="systemic" post="circulation, which can cause activation of innate immune response"/>
  <result pre="Right myocardial strain can be seen as a result of" exact="pulmonary embolism," post="which has been reported as the most common thrombotic"/>
  <result pre="common thrombotic complication in COVID-19 patients (53), or due to" exact="pulmonary" post="hypertension, causing increased right sided pressures secondary to severe"/>
  <result pre="or due to pulmonary hypertension, causing increased right sided pressures" exact="secondary" post="to severe ARDS, sepsis, or heart failure (54). On"/>
  <result pre="increased right sided pressures secondary to severe ARDS, sepsis, or" exact="heart" post="failure (54). On the one hand, increased right atrial"/>
  <result pre="atrial pressure along with increased sympathetic tone in patients with" exact="pulmonary" post="hypertension and hypoxia can predispose to increased risk of"/>
  <result pre="pressure along with increased sympathetic tone in patients with pulmonary" exact="hypertension" post="and hypoxia can predispose to increased risk of atrial"/>
  <result pre="with increased sympathetic tone in patients with pulmonary hypertension and" exact="hypoxia" post="can predispose to increased risk of atrial tachyarrhythmias (55)."/>
  <result pre="been previously described in this review, was found to have" exact="transient" post="complete heart block suggested to be due to transient"/>
  <result pre="previously described in this review, was found to have transient" exact="complete" post="heart block suggested to be due to transient pulmonary"/>
  <result pre="described in this review, was found to have transient complete" exact="heart" post="block suggested to be due to transient pulmonary artery"/>
  <result pre="have transient complete heart block suggested to be due to" exact="transient" post="pulmonary artery hypertension (20). Electrolyte derangements Arrhythmias due to"/>
  <result pre="transient complete heart block suggested to be due to transient" exact="pulmonary" post="artery hypertension (20). Electrolyte derangements Arrhythmias due to electrolyte"/>
  <result pre="heart block suggested to be due to transient pulmonary artery" exact="hypertension" post="(20). Electrolyte derangements Arrhythmias due to electrolyte abnormalities as"/>
  <result pre="be due to transient pulmonary artery hypertension (20). Electrolyte derangements" exact="Arrhythmias" post="due to electrolyte abnormalities as well as its effect"/>
  <result pre="were reported in 7.2% of 416 hospitalized patients with COVID-19" exact="infection" post="(5). These were attributed to COVID-19â€&quot;associated diarrhea or from"/>
  <result pre="patients with COVID-19 infection (5). These were attributed to COVID-19â€&quot;associated" exact="diarrhea" post="or from renal injury, among other cases. In a"/>
  <result pre="cases. In a retrospective analysis by Diao etÂ al. (57)," exact="acute" post="kidney injury was reported in 27% of 85 patients"/>
  <result pre="In a retrospective analysis by Diao etÂ al. (57), acute" exact="kidney injury" post="was reported in 27% of 85 patients hospitalized with"/>
  <result pre="noted to have severe electrolyte disturbances including hypokalemia, hypomagnesemia, and" exact="hypophosphatemia" post="(24). Intravascular volume imbalances Fluid disturbances are commonly encountered"/>
  <result pre="be ascribed to sepsis caused from ARDS or due to" exact="heart" post="failure. The most commonly encountered arrhythmia in the critical"/>
  <result pre="ARDS or due to heart failure. The most commonly encountered" exact="arrhythmia" post="in the critical care setting, which can be caused"/>
  <result pre="caused due to the previously described mechanism among others, is" exact="atrial fibrillation" post="(58). Drug side effects Many of the â€œoff-labelâ€� COVID-19"/>
  <result pre="due to the previously described mechanism among others, is atrial" exact="fibrillation" post="(58). Drug side effects Many of the â€œoff-labelâ€� COVID-19"/>
  <result pre="other COVID-19 therapies including ribavirin, remdesivir, and tocilizumab. Management of" exact="Arrhythmias" post="With COVID-19 The goal of managing arrhythmias in patients"/>
  <result pre="There are not enough clinical studies to guide management of" exact="arrhythmia" post="in confirmed COVID-19 cases. Treatment of any bradyarrhythmias or"/>
  <result pre="should be similar to treatment as in any patient with" exact="arrhythmia" post="due to infection or transient metabolic disturbances. Special consideration"/>
  <result pre="to treatment as in any patient with arrhythmia due to" exact="infection" post="or transient metabolic disturbances. Special consideration should be given"/>
  <result pre="as in any patient with arrhythmia due to infection or" exact="transient" post="metabolic disturbances. Special consideration should be given to management"/>
  <result pre="be given to management of arrhythmias in patients with inherited" exact="arrhythmia" post="syndrome and management of QTc prolongation while receiving COVID"/>
  <result pre="given to management of arrhythmias in patients with inherited arrhythmia" exact="syndrome" post="and management of QTc prolongation while receiving COVID therapy."/>
  <result pre="European Society of Cardiology (61) as well as the Latin" exact="American" post="Heart Rhythm Society in collaboration with the Colombian, Argentinian,"/>
  <result pre="Society of Cardiology (61) as well as the Latin American" exact="Heart" post="Rhythm Society in collaboration with the Colombian, Argentinian, Brazilian,"/>
  <result pre="collaboration with the Colombian, Argentinian, Brazilian, and Mexican Societies of" exact="Cardiac" post="Electrophysiology (62) have provided a consensus document for management"/>
  <result pre="various arrhythmias in a confirmed COVID-19 patients, focusing on the" exact="transient" post="nature of arrhythmias, drug-drug interactions, and limiting exposure and"/>
  <result pre="The recommendations are summarized subsequently. Bradyarrhythmias Bradycardia including sinus or" exact="AV block" post="in COVID-19 patients can be seen because of drug"/>
  <result pre="lopinavir/rotinavir, and azithromycin. AV blocks could also be seen in" exact="myocarditis" post="if there is involvement of the conduction system. Intubated"/>
  <result pre="is involvement of the conduction system. Intubated patients can experience" exact="transient" post="bradycardia during tracheal secretion suctioning or during proning of"/>
  <result pre="secretion suctioning or during proning of the patient due to" exact="transient" post="increased vagal tone. In patients with persistent bradycardia, use"/>
  <result pre="option prior to implanting a permanent device due to the" exact="transient" post="nature of bradyarrhythmias, nature of critical illness, risk of"/>
  <result pre="transient nature of bradyarrhythmias, nature of critical illness, risk of" exact="bacterial" post="superinfection, and risk of device infection. However, evaluation of"/>
  <result pre="a permanent pacemaker should be reassessed after recovery from COVID-19" exact="infection" post="(62). Atrial tachyarrhythmias (supraventricular tachycardia and atrial fibrillation or"/>
  <result pre="recovery from COVID-19 infection (62). Atrial tachyarrhythmias (supraventricular tachycardia and" exact="atrial fibrillation" post="or flutter) It is important to identify and treat"/>
  <result pre="from COVID-19 infection (62). Atrial tachyarrhythmias (supraventricular tachycardia and atrial" exact="fibrillation" post="or flutter) It is important to identify and treat"/>
  <result pre="fibrillation or flutter) It is important to identify and treat" exact="secondary" post="causes of atrial tachyarrhythmias like hypoxia, metabolic and electrolyte"/>
  <result pre="hypoxia, metabolic and electrolyte imbalances, proarrhythmic effect of drugs, or" exact="myocardial ischemia." post="In patients with supraventricular tachycardia, intravenous adenosine can be"/>
  <result pre="patients with supraventricular tachycardia, intravenous adenosine can be used for" exact="acute" post="termination, although further validation is needed. Electrical cardioversion can"/>
  <result pre="in patients with refractory cases and should be postponed in" exact="stable" post="and asymptomatic patients. One should have a low threshold"/>
  <result pre="to avoid bradycardia and QT prolongation (61,62). In patients with" exact="recurrent" post="atrial fibrillation and flutter who are hemodynamically stable, consider"/>
  <result pre="avoid bradycardia and QT prolongation (61,62). In patients with recurrent" exact="atrial fibrillation" post="and flutter who are hemodynamically stable, consider discontinuing antiarrhythmic"/>
  <result pre="bradycardia and QT prolongation (61,62). In patients with recurrent atrial" exact="fibrillation" post="and flutter who are hemodynamically stable, consider discontinuing antiarrhythmic"/>
  <result pre="with or without digoxin. Similarly, patients with new onset of" exact="atrial fibrillation" post="or flutter with a stable rhythm can be treated"/>
  <result pre="or without digoxin. Similarly, patients with new onset of atrial" exact="fibrillation" post="or flutter with a stable rhythm can be treated"/>
  <result pre="with new onset of atrial fibrillation or flutter with a" exact="stable" post="rhythm can be treated with rate control. Rhythm control"/>
  <result pre="be reserved for patients with hemodynamically unstable patients or in" exact="congestive heart failure" post="patients (61,62). There is a high risk of immediate"/>
  <result pre="reserved for patients with hemodynamically unstable patients or in congestive" exact="heart" post="failure patients (61,62). There is a high risk of"/>
  <result pre="(61,62). There is a high risk of immediate recurrence of" exact="arrhythmia" post="without the use of any AAD as maintenance therapy,"/>
  <result pre="AAD as maintenance therapy, which can be minimized by treating" exact="secondary" post="causes of arrhythmias prior to attempting rhythm control strategy."/>
  <result pre="Thus, it is imperative to note that the CHA2DS2-VASc (congestive" exact="heart" post="failure, hypertension, ageÂ â‰¥75 years, diabetes mellitus, prior stroke"/>
  <result pre="that the CHA2DS2-VASc (congestive heart failure, hypertension, ageÂ â‰¥75 years," exact="diabetes mellitus," post="prior stroke or transient ischemic attack or thromboembolism, vascular"/>
  <result pre="(congestive heart failure, hypertension, ageÂ â‰¥75 years, diabetes mellitus, prior" exact="stroke" post="or transient ischemic attack or thromboembolism, vascular disease, age"/>
  <result pre="failure, hypertension, ageÂ â‰¥75 years, diabetes mellitus, prior stroke or" exact="transient ischemic attack" post="or thromboembolism, vascular disease, age 65â€&quot;74 years, sex category)"/>
  <result pre="diabetes mellitus, prior stroke or transient ischemic attack or thromboembolism," exact="vascular" post="disease, age 65â€&quot;74 years, sex category) score may underestimate"/>
  <result pre="TTE, which would necessitate escalation of immunosuppressants in patients with" exact="myocarditis" post="(61,62). Cardiac computed tomography can be considered to rule"/>
  <result pre="would necessitate escalation of immunosuppressants in patients with myocarditis (61,62)." exact="Cardiac" post="computed tomography can be considered to rule out left"/>
  <result pre="echocardiography if rhythm control is needed. Data suggest that COVID-19" exact="infection" post="can be associated with a hypercoagulable state that might"/>
  <result pre="and the need for anticoagulation after recovering from COVID-19 infection." exact="Ventricular" post="Arrhythmias It is important to identify and treat secondary"/>
  <result pre="the need for anticoagulation after recovering from COVID-19 infection. Ventricular" exact="Arrhythmias" post="It is important to identify and treat secondary causes"/>
  <result pre="infection. Ventricular Arrhythmias It is important to identify and treat" exact="secondary" post="causes like hypoxia, metabolic or electrolyte imbalances, and proarrhythmic"/>
  <result pre="electrolyte imbalances, and proarrhythmic effects of drugs. In patients with" exact="ventricular tachycardia" post="storm not related to the previously mentioned causes, the"/>
  <result pre="of therapy is amiodarone or intravenous lidocaine, especially if underlying" exact="myocardial infarction" post="is suspected, in addition to sympathetic blockade with esmolol,"/>
  <result pre="with esmolol, sedation, and possible intubation. In patients with polymorphic" exact="ventricular tachycardia" post="or ventricular fibrillation with prolonged QTc interval, replace electrolytes"/>
  <result pre="and possible intubation. In patients with polymorphic ventricular tachycardia or" exact="ventricular fibrillation" post="with prolonged QTc interval, replace electrolytes to target potassium"/>
  <result pre="possible intubation. In patients with polymorphic ventricular tachycardia or ventricular" exact="fibrillation" post="with prolonged QTc interval, replace electrolytes to target potassium"/>
  <result pre="bedside in emergency situations can be considered to overdrive terminate" exact="ventricular tachycardia" post="and incase of recurrent TdP or bradycardia (61). One"/>
  <result pre="be considered to overdrive terminate ventricular tachycardia and incase of" exact="recurrent" post="TdP or bradycardia (61). One should also assess the"/>
  <result pre="membrane oxygenation (62). Consider TTE in patients with new onset" exact="malignant" post="ventricular arrhythmia if not related to QT prolongation. After"/>
  <result pre="(62). Consider TTE in patients with new onset malignant ventricular" exact="arrhythmia" post="if not related to QT prolongation. After recovery from"/>
  <result pre="QT prolongation. After recovery from COVID-19, evaluate the need for" exact="secondary" post="prevention ICD and catheter ablation. If transient cardiomyopathy due"/>
  <result pre="the need for secondary prevention ICD and catheter ablation. If" exact="transient" post="cardiomyopathy due to myocarditis is suspected, consider wearable defibrillator"/>
  <result pre="need for secondary prevention ICD and catheter ablation. If transient" exact="cardiomyopathy" post="due to myocarditis is suspected, consider wearable defibrillator devices"/>
  <result pre="prevention ICD and catheter ablation. If transient cardiomyopathy due to" exact="myocarditis" post="is suspected, consider wearable defibrillator devices (61). Channelopathies and"/>
  <result pre="myocarditis is suspected, consider wearable defibrillator devices (61). Channelopathies and" exact="Inherited" post="Arrhythmia Syndrome In patients with LQTS, monitor the QT"/>
  <result pre="is suspected, consider wearable defibrillator devices (61). Channelopathies and Inherited" exact="Arrhythmia" post="Syndrome In patients with LQTS, monitor the QT interval"/>
  <result pre="suspected, consider wearable defibrillator devices (61). Channelopathies and Inherited Arrhythmia" exact="Syndrome" post="In patients with LQTS, monitor the QT interval and"/>
  <result pre="LQTS (except with specific LQTS2 mutation). Whereas in patients with" exact="Brugada syndrome" post="(BrS), fever can unmask the ECG manifestation of type"/>
  <result pre="(except with specific LQTS2 mutation). Whereas in patients with Brugada" exact="syndrome" post="(BrS), fever can unmask the ECG manifestation of type"/>
  <result pre="Brugada syndrome (BrS), fever can unmask the ECG manifestation of" exact="type 1" post="BrS, and thus it is recommended that all patients"/>
  <result pre="the emergency room and kept under observation if ECG shows" exact="type 1" post="pattern; otherwise, the patient can be discharged home to"/>
  <result pre="to limit exposure to SARS-CoV-2 in the hospital. Patients with" exact="catecholaminergic polymorphic ventricular tachycardia" post="have adrenergic-related ventricular arrhythmias; thus, catecholamine infusions should be"/>
  <result pre="exposure to SARS-CoV-2 in the hospital. Patients with catecholaminergic polymorphic" exact="ventricular tachycardia" post="have adrenergic-related ventricular arrhythmias; thus, catecholamine infusions should be"/>
  <result pre="be continued while monitoring interactions with antiviral drugs. Patients with" exact="short QT syndrome" post="do not seem to be at particular risk with"/>
  <result pre="while monitoring interactions with antiviral drugs. Patients with short QT" exact="syndrome" post="do not seem to be at particular risk with"/>
  <result pre="controlled trial, CloroCOVID-19 trial (Chloroquine Diphosphate for the Treatment of" exact="Severe" post="Acute Respiratory Syndrome Secondary to SARS-COV2), studying the effect"/>
  <result pre="trial, CloroCOVID-19 trial (Chloroquine Diphosphate for the Treatment of Severe" exact="Acute" post="Respiratory Syndrome Secondary to SARS-COV2), studying the effect of"/>
  <result pre="CloroCOVID-19 trial (Chloroquine Diphosphate for the Treatment of Severe Acute" exact="Respiratory" post="Syndrome Secondary to SARS-COV2), studying the effect of low-dose"/>
  <result pre="trial (Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory" exact="Syndrome" post="Secondary to SARS-COV2), studying the effect of low-dose (450Â"/>
  <result pre="(Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome" exact="Secondary" post="to SARS-COV2), studying the effect of low-dose (450Â mg"/>
  <result pre="risk patients (69). It consists ofÂ â‰¥68 years of age," exact="female" post="sex, use of loop diuretics, potassium levelÂ â‰¤3.5 mEq/l,"/>
  <result pre="diuretics, potassium levelÂ â‰¤3.5 mEq/l, baseline QTc intervalÂ â‰¥450Â ms," exact="acute" post="myocardial infarction, number of QT-prolonging medications, sepsis, and heart"/>
  <result pre="potassium levelÂ â‰¤3.5 mEq/l, baseline QTc intervalÂ â‰¥450Â ms, acute" exact="myocardial infarction," post="number of QT-prolonging medications, sepsis, and heart failure. A"/>
  <result pre="â‰¥450Â ms, acute myocardial infarction, number of QT-prolonging medications, sepsis," exact="and heart" post="failure. A score ofÂ â‰¤6 predicts low risk, 7"/>
  <result pre="ms, acute myocardial infarction, number of QT-prolonging medications, sepsis, and" exact="heart" post="failure. A score ofÂ â‰¤6 predicts low risk, 7"/>
  <result pre="home QTc-prolonging medication can be discontinued and to document high-risk" exact="cardiovascular" post="and comorbid conditions. QTc interval can be measured using"/>
  <result pre="ms in post-pubertal male patients, andÂ &amp;lt;480Â ms in post-pubertal" exact="female" post="patients is considered low risk to prescribe or continue"/>
  <result pre="telemetry, with consideration of a wearable defibrillator or placement of" exact="external" post="defibrillator patches. In patients with a wide QRS either"/>
  <result pre="to slightly shorten the QT interval and suppress TdP in" exact="acquired" post="LQTS. Other known therapies to alleviate risk of TdP,"/>
  <result pre="risk of TdP, such as maintaining potassium and magnesium levels" exact="and heart" post="rates &amp;gt;70 beats/min have also been described (72). Cardiac"/>
  <result pre="of TdP, such as maintaining potassium and magnesium levels and" exact="heart" post="rates &amp;gt;70 beats/min have also been described (72). Cardiac"/>
  <result pre="and heart rates &amp;gt;70 beats/min have also been described (72)." exact="Cardiac" post="drug interaction with COVID-19 therapy Another important consideration during"/>
  <result pre="1 Possible Interactions of Drugs Used for COVID-19 Therapy With" exact="Cardiac" post="Drugs Treatment Select Drug-Drug Interactionsâˆ— Azithromycin â†&quot; in HR,"/>
  <result pre="blocker; COVID-19Â =Â coronavirus disease-2019; ECGÂ =Â electrocardiography; HRÂ =Â" exact="heart" post="rate; TdPÂ =Â torsades de pointes âˆ—Severe: drugs should"/>
  <result pre="routinely used by health care providers to protect themselves from" exact="infectious" post="conditions and toxic substances. The fundamental goal is to"/>
  <result pre="except for some cardiac arrhythmias, which require urgent interventions. The" exact="Heart" post="Rhythm Society COVID-19 task force (75) has put together"/>
  <result pre="COVID-19 symptoms and should undergo COVID-19 testing. In locations with" exact="limited" post="testing availability or with concern for community spread, it"/>
  <result pre="and the smoke produced can have a significant amount of" exact="viral" post="load. Surgical data recommend using low power electrocautery settings"/>
  <result pre="to support this. Apart from considerations for electrophysiology procedures, the" exact="Heart" post="Rhythm Society COVID-19 task force document (75) also provides"/>
  <result pre="outpatient setting via telemedicine as well as regarding minimizing in-person" exact="cardiovascular" post="implantable electronic device interrogation via remote device monitoring. Conclusions"/>
  <result pre="arrhythmias in COVID-19 patients is likely as a result of" exact="systemic" post="illness and not merely as a result of direct"/>
  <result pre="not merely as a result of direct effect of the" exact="viral infection." post="To manage arrhythmias in patients with COVID-19, it is"/>
  <result pre="COVIDm-19 therapy, and provide special considerations for patients with inherited" exact="arrhythmia" post="syndromes. It is also crucial to minimize exposure to"/>
  <result pre="syndromes. It is also crucial to minimize exposure to COVID-19" exact="infection" post="by stratifying the need for intervention and using telemedicine."/>
  <result pre="stratifying the need for intervention and using telemedicine. As COVID-19" exact="infection" post="continues to prevail with a potential for future surges,"/>
  <result pre="J Med38220201194119632074416 4ZhouF.YuT.DuR.Clinical course and risk factors for mortality of" exact="adult" post="inpatients with COVID-19 in Wuhan, China: a retrospective cohort"/>
  <result pre="Cardiology5202080281032211816 6GuoT.FanY.ChenM.Cardiovascular implications of fatal outcomes of patients with coronavirus" exact="disease" post="2019 (COVID-19)JAMA Cardiol5202018 7PuntmannV.O.CarerjM.L.WietersI.Outcomes of cardiovascular magnetic resonance imaging"/>
  <result pre="of patients with coronavirus disease 2019 (COVID-19)JAMA Cardiol5202018 7PuntmannV.O.CarerjM.L.WietersI.Outcomes of" exact="cardiovascular" post="magnetic resonance imaging in patients recently recovered from coronavirus"/>
  <result pre="cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus" exact="disease" post="2019 (COVID-19)JAMA Cardiol2020 July 27[E-pub ahead of print]. 8YuC.-M.WongR.S.-M.WuE.B.Cardiovascular"/>
  <result pre="Cardiol2020 July 27[E-pub ahead of print]. 8YuC.-M.WongR.S.-M.WuE.B.Cardiovascular complications of severe" exact="acute" post="respiratory syndromePostgrad Med J82200614014416461478 9SaadM.OmraniA.S.BaigK.Clinical aspects and outcomes of"/>
  <result pre="July 27[E-pub ahead of print]. 8YuC.-M.WongR.S.-M.WuE.B.Cardiovascular complications of severe acute" exact="respiratory" post="syndromePostgrad Med J82200614014416461478 9SaadM.OmraniA.S.BaigK.Clinical aspects and outcomes of 70"/>
  <result pre="9SaadM.OmraniA.S.BaigK.Clinical aspects and outcomes of 70 patients with Middle East" exact="respiratory" post="syndrome coronavirus infection: a single-center experience in Saudi ArabiaInt"/>
  <result pre="aspects and outcomes of 70 patients with Middle East respiratory" exact="syndrome" post="coronavirus infection: a single-center experience in Saudi ArabiaInt J"/>
  <result pre="potential therapeutic strategiesJÂ Am Coll Cardiol Basic Trans Sci52020518536 11EstabraghZ.R.MamasM.A.The" exact="cardiovascular" post="manifestations of influenza: a systematic reviewInt J Cardiol16720132397240323474244 12MadjidM.ConnollyA.T.NabutovskyY.Safavi-NaeiniP.RazaviM.MillerC.C.Effect"/>
  <result pre="14WangD.HuB.HuC.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusâ€&quot;infected" exact="pneumonia" post="in Wuhan, ChinaJAMA32320201061106932031570 15SalaS.PerettoG.De LucaG.Low prevalence of arrhythmias in"/>
  <result pre="in Wuhan, ChinaJAMA32320201061106932031570 15SalaS.PerettoG.De LucaG.Low prevalence of arrhythmias in clinically" exact="stable" post="COVID-19 patientsPacing Clin Electrophysiol2020 Jun 16[E-pub ahead of print]"/>
  <result pre="CollÂ Cardiol EP2020 May 28[E-pub ahead of print] 18AzarkishM.Laleh FarV.EslamiM.MollazadehR.Transient" exact="complete" post="heart block in a patient with critical COVID-19Eur Heart"/>
  <result pre="Cardiol EP2020 May 28[E-pub ahead of print] 18AzarkishM.Laleh FarV.EslamiM.MollazadehR.Transient complete" exact="heart" post="block in a patient with critical COVID-19Eur Heart J412020213132285920"/>
  <result pre="FarV.EslamiM.MollazadehR.Transient complete heart block in a patient with critical COVID-19Eur" exact="Heart" post="J412020213132285920 19KirD.MohanC.SancassaniR.HEART BRAKE-an unusual cardiac manifestation of coronavirus disease"/>
  <result pre="COVID-19Eur Heart J412020213132285920 19KirD.MohanC.SancassaniR.HEART BRAKE-an unusual cardiac manifestation of coronavirus" exact="disease" post="2019 (COVID-19)JÂ Am Coll Cardiol Case Rep2202012521255 20HeJ.WuB.ChenY.Characteristic ECG"/>
  <result pre="Mar 29[E-pub ahead of print] 21BirchakJ.KhanA.SinghG.SchugerC.MaskounW.An unusual case of sustained" exact="ventricular tachycardia" post="from acute pulmonary embolismJÂ Am Coll Cardiol7520202820 22NaksukN.LazarS.PeeraphatditT.B.Cardiac safety"/>
  <result pre="of print] 21BirchakJ.KhanA.SinghG.SchugerC.MaskounW.An unusual case of sustained ventricular tachycardia from" exact="acute" post="pulmonary embolismJÂ Am Coll Cardiol7520202820 22NaksukN.LazarS.PeeraphatditT.B.Cardiac safety of off-label"/>
  <result pre="print] 21BirchakJ.KhanA.SinghG.SchugerC.MaskounW.An unusual case of sustained ventricular tachycardia from acute" exact="pulmonary" post="embolismJÂ Am Coll Cardiol7520202820 22NaksukN.LazarS.PeeraphatditT.B.Cardiac safety of off-label COVID-19"/>
  <result pre="off-label COVID-19 drug therapy: a review and proposed monitoring protocolEur" exact="Heart" post="J Acute Cardiovasc Care2009215221 23VidovichM.I.Transient Brugada-like ECG pattern in"/>
  <result pre="drug therapy: a review and proposed monitoring protocolEur Heart J" exact="Acute" post="Cardiovasc Care2009215221 23VidovichM.I.Transient Brugada-like ECG pattern in a patient"/>
  <result pre="Care2009215221 23VidovichM.I.Transient Brugada-like ECG pattern in a patient with coronavirus" exact="disease" post="2019 (COVID-19)JÂ Am Coll Cardiol Case Rep2202012451249 24SeecheranR.NarayansinghR.GiddingsS.Atrial arrhythmias"/>
  <result pre="25KochavS.M.CoromilasE.NalbandianA.Cardiac arrhythmias in COVID-19 infectionCirc Arrhythm Electrophysiol132020e008719 26XiongT.-Y.RedwoodS.PrendergastB.ChenM.Coronaviruses and the" exact="cardiovascular" post="system: acute and long-term implicationsEur Heart J4120201798180032186331 27Babapoor-FarrokhranS.GillD.WalkerJ.RasekhiR.T.BozorgniaB.AmanullahA.Myocardial injury"/>
  <result pre="in COVID-19 infectionCirc Arrhythm Electrophysiol132020e008719 26XiongT.-Y.RedwoodS.PrendergastB.ChenM.Coronaviruses and the cardiovascular system:" exact="acute" post="and long-term implicationsEur Heart J4120201798180032186331 27Babapoor-FarrokhranS.GillD.WalkerJ.RasekhiR.T.BozorgniaB.AmanullahA.Myocardial injury and COVID-19:"/>
  <result pre="Electrophysiol132020e008719 26XiongT.-Y.RedwoodS.PrendergastB.ChenM.Coronaviruses and the cardiovascular system: acute and long-term implicationsEur" exact="Heart" post="J4120201798180032186331 27Babapoor-FarrokhranS.GillD.WalkerJ.RasekhiR.T.BozorgniaB.AmanullahA.Myocardial injury and COVID-19: possible mechanismsLife Sci253202011772332360126 28KochiA.N.TagliariA.P.ForleoG.B.FassiniG.M.TondoC.Cardiac"/>
  <result pre="print] 30LazzeriniP.E.BoutjdirM.CapecchiP.L.COVID-19, arrhythmic risk and inflammation: mind the gap!Circulation14220207932286863 31KolettisT.M.Coronary" exact="artery disease" post="and ventricular tachyarrhythmia: pathophysiology and treatmentCurr Opin Pharmacol13201321021723357129 32SiripanthongB.NazarianS.MuserD.Recognizing"/>
  <result pre="30LazzeriniP.E.BoutjdirM.CapecchiP.L.COVID-19, arrhythmic risk and inflammation: mind the gap!Circulation14220207932286863 31KolettisT.M.Coronary artery" exact="disease" post="and ventricular tachyarrhythmia: pathophysiology and treatmentCurr Opin Pharmacol13201321021723357129 32SiripanthongB.NazarianS.MuserD.Recognizing"/>
  <result pre="in myocarditis: State of the artHeart Rhythm16201979380130476544 34LindnerD.FitzekA.BrÃ¤uningerH.Association of cardiac" exact="infection" post="with SARS-CoV-2 in confirmed COVID-19 autopsy casesJAMA Cardiol2020 Jul"/>
  <result pre="16[E-pub ahead of print] 38TseG.YeoJ.M.ChanY.W.LaiE.T.YanB.P.What is the arrhythmic substrate in" exact="viral" post="myocarditis? Insights from clinical and animal studiesFront Physiol7201630827493633 39TavazziG.PellegriniC.MaurelliM.Myocardial"/>
  <result pre="Physiol7201630827493633 39TavazziG.PellegriniC.MaurelliM.Myocardial localization of coronavirus in COVID-19 cardiogenic shockEur J" exact="Heart" post="Fail22202091191532275347 40PuntmannV.O.TaylorP.C.BarrA.SchnackenburgB.JahnkeC.PaetschI.Towards understanding the phenotypes of myocardial involvement in"/>
  <result pre="of myocardial involvement in the presence of self-limiting and sustained" exact="systemic" post="inflammation: a magnetic resonance imaging studyRheumatology (Oxford)49201052853520026563 41LazzeriniP.E.CapecchiP.L.Laghi-PasiniF.Long QT"/>
  <result pre="and immunityFront Cardiovasc Med220152626798623 42LazzeriniP.E.Laghi-PasiniF.BoutjdirM.CapecchiP.L.Cardioimmunology of arrhythmias: the role of" exact="autoimmune" post="and inflammatory cardiac channelopathiesNat Rev Immunol192019636430552387 43LazzeriniP.E.CapecchiP.L.Laghi-PasiniF.Systemic inflammation and"/>
  <result pre="Immunol192019636430552387 43LazzeriniP.E.CapecchiP.L.Laghi-PasiniF.Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritisEur" exact="Heart" post="J3820171717172727252448 44YanowitzF.PrestonJ.B.AbildskovJ.A.Functional distribution of right and left stellate innervation"/>
  <result pre="innervation to the ventricles: production of neurogenic electrocardiographs changes by" exact="unilateral" post="alteration of sympathetic toneCirc Res1819664164284952701 45LazzeriniP.E.AcampaM.CapecchiP.L.Antiarrhythmic potential of anticytokine"/>
  <result pre="in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling" exact="systemic" post="inflammationArthritis Care Res672015332339 46TangN.LiD.WangX.SunZ.Abnormal coagulation parameters are associated with"/>
  <result pre="J Med370201484785924571757 48HuertasA.MontaniD.SavaleL.Endothelial cell dysfunction: a major player in SARS-CoV-2" exact="infection" post="(COVID-19)?Eur Respir J562020200163432554538 49VargaZ.FlammerA.J.SteigerP.Endothelial cell infection and endotheliitis in"/>
  <result pre="major player in SARS-CoV-2 infection (COVID-19)?Eur Respir J562020200163432554538 49VargaZ.FlammerA.J.SteigerP.Endothelial cell" exact="infection" post="and endotheliitis in COVID-19Lancet39520201417141832325026 50BangaloreS.SharmaA.SlotwinerA.ST-segment elevation in patients with"/>
  <result pre="in patients with Covid-19â€&quot;A case seriesNÂ Engl J Med2020 51MusherD.M.AbersM.S.Corrales-MedinaV.F.Acute" exact="infection" post="and myocardial infarctionNÂ Engl J Med380201917117630625066 52VeerdonkFL van devan"/>
  <result pre="complications in critically ill ICU patients with COVID-19Thromb Res191202014514732291094 54Ã‘amendys-SilvaS.A.Santos-MartÃ­nezL.E.PulidoT.Pulmonary" exact="hypertension" post="due to acute respiratory distress syndromeBraz J Med Biol"/>
  <result pre="ill ICU patients with COVID-19Thromb Res191202014514732291094 54Ã‘amendys-SilvaS.A.Santos-MartÃ­nezL.E.PulidoT.Pulmonary hypertension due to" exact="acute" post="respiratory distress syndromeBraz J Med Biol Res47201490491025118626 55WanamakerB.CascinoT.McLaughlinV.OralH.LatchamsettyR.SiontisK.C.Atrial arrhythmias"/>
  <result pre="ICU patients with COVID-19Thromb Res191202014514732291094 54Ã‘amendys-SilvaS.A.Santos-MartÃ­nezL.E.PulidoT.Pulmonary hypertension due to acute" exact="respiratory" post="distress syndromeBraz J Med Biol Res47201490491025118626 55WanamakerB.CascinoT.McLaughlinV.OralH.LatchamsettyR.SiontisK.C.Atrial arrhythmias in"/>
  <result pre="respiratory distress syndromeBraz J Med Biol Res47201490491025118626 55WanamakerB.CascinoT.McLaughlinV.OralH.LatchamsettyR.SiontisK.C.Atrial arrhythmias in" exact="pulmonary" post="hypertension: pathogenesis, prognosis and managementArrhythm Electrophysiol Rev72018434829636972 56SurawiczB.Role of"/>
  <result pre="Cardiovasc Dis819663643865323242 57DiaoB.WangC.WangR.Human kidney is a target for novel severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) infectionmedRxiv2020 Mar 5[E-pub ahead"/>
  <result pre="Dis819663643865323242 57DiaoB.WangC.WangR.Human kidney is a target for novel severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) infectionmedRxiv2020 Mar 5[E-pub ahead of"/>
  <result pre="57DiaoB.WangC.WangR.Human kidney is a target for novel severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) infectionmedRxiv2020 Mar 5[E-pub ahead of print]"/>
  <result pre="coronavirus 2 (SARS-CoV-2) infectionmedRxiv2020 Mar 5[E-pub ahead of print] 58BoschN.A.CiminiJ.WalkeyA.J.Atrial" exact="fibrillation" post="in the ICUChest15420181424143429627355 59GiudicessiJ.R.NoseworthyP.A.FriedmanP.A.AckermanM.J.Urgent guidance for navigating and circumventing"/>
  <result pre="the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus" exact="disease" post="19 (COVID-19)Mayo Clin Proc9520201213122132359771 60MercuroN.J.YenC.F.ShimD.J.Risk of QT interval prolongation"/>
  <result pre="without concomitant azithromycin among hospitalized patients testing positive for coronavirus" exact="disease" post="2019 (COVID-19)JAMA Cardiol2020 May 1[E-pub ahead of print] 61ESC"/>
  <result pre="print] 61ESC Guidance for the Diagnosis and Management of CV" exact="Disease" post="during the COVID-19 PandemicAvailable at:https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance 62SaenzL.C.MirandaA.SperanzaR.Recommendations for the organization"/>
  <result pre="electrophysiology and cardiac pacing services during the COVID-19 pandemic: Latin" exact="American" post="Heart Rhythm Society (LAHRS) in collaboration with: Colombian College"/>
  <result pre="and cardiac pacing services during the COVID-19 pandemic: Latin American" exact="Heart" post="Rhythm Society (LAHRS) in collaboration with: Colombian College Of"/>
  <result pre="in collaboration with: Colombian College Of Electrophysiology, Argentinian Society of" exact="Cardiac" post="Electrophysiology (SADEC), Brazilian Society Of Cardiac Arrhythmias (SOBRAC), Mexican"/>
  <result pre="Colombian College Of Electrophysiology, Argentinian Society of Cardiac Electrophysiology (SADEC)," exact="Brazilian" post="Society Of Cardiac Arrhythmias (SOBRAC), Mexican Society Of Cardiac"/>
  <result pre="Electrophysiology, Argentinian Society of Cardiac Electrophysiology (SADEC), Brazilian Society Of" exact="Cardiac" post="Arrhythmias (SOBRAC), Mexican Society Of Cardiac Electrophysiology (SOMEEC)JÂ Interv"/>
  <result pre="Argentinian Society of Cardiac Electrophysiology (SADEC), Brazilian Society Of Cardiac" exact="Arrhythmias" post="(SOBRAC), Mexican Society Of Cardiac Electrophysiology (SOMEEC)JÂ Interv Card"/>
  <result pre="(SADEC), Brazilian Society Of Cardiac Arrhythmias (SOBRAC), Mexican Society Of" exact="Cardiac" post="Electrophysiology (SOMEEC)JÂ Interv Card Electrophysiol2020 Apr 29[E-pub ahead of"/>
  <result pre="Card Electrophysiol2020 Apr 29[E-pub ahead of print] 63RattanawongP.ShenW.El MasryH.Guidance on" exact="acute" post="management of atrial fibrillation in COVID-19JÂ Am Heart Assoc92020e017529"/>
  <result pre="29[E-pub ahead of print] 63RattanawongP.ShenW.El MasryH.Guidance on acute management of" exact="atrial fibrillation" post="in COVID-19JÂ Am Heart Assoc92020e017529 64HelmsJ.TacquardC.SeveracF.High risk of thrombosis"/>
  <result pre="ahead of print] 63RattanawongP.ShenW.El MasryH.Guidance on acute management of atrial" exact="fibrillation" post="in COVID-19JÂ Am Heart Assoc92020e017529 64HelmsJ.TacquardC.SeveracF.High risk of thrombosis"/>
  <result pre="MasryH.Guidance on acute management of atrial fibrillation in COVID-19JÂ Am" exact="Heart" post="Assoc92020e017529 64HelmsJ.TacquardC.SeveracF.High risk of thrombosis in patients with severe"/>
  <result pre="atrial fibrillation in COVID-19JÂ Am Heart Assoc92020e017529 64HelmsJ.TacquardC.SeveracF.High risk of" exact="thrombosis" post="in patients with severe SARS-CoV-2 infection: a multicenter prospective"/>
  <result pre="a multicenter prospective cohort studyIntensive Care Med4620201089109832367170 65LeviM.ThachilJ.IbaT.LevyJ.H.Coagulation abnormalities and" exact="thrombosis" post="in patients with COVID-19Lancet Haematol72020e438e44032407672 66WuC.-I.PostemaP.G.ArbeloE.SARS-CoV-2, COVID-19 and inherited"/>
  <result pre="thrombosis in patients with COVID-19Lancet Haematol72020e438e44032407672 66WuC.-I.PostemaP.G.ArbeloE.SARS-CoV-2, COVID-19 and inherited" exact="arrhythmia" post="syndromesHeart Rhythm2020 Mar 31[E-pub ahead of print] 67RamireddyA.ChughH.S.ReinierK.Experience with"/>
  <result pre="in the COVID-19 pandemic: implications for QT interval monitoringJÂ Am" exact="Heart" post="Assoc92020e017144 68BorbaM.G.S.ValF.F.A.SampaioV.S.Effect of high vs low doses of chloroquine"/>
  <result pre="chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) infectionJAMA Netw Open32020e208857 69MalviyaA.Ventricular"/>
  <result pre="diphosphate as adjunctive therapy for patients hospitalized with severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) infectionJAMA Netw Open32020e208857 69MalviyaA.Ventricular arrhythmia"/>
  <result pre="as adjunctive therapy for patients hospitalized with severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) infectionJAMA Netw Open32020e208857 69MalviyaA.Ventricular arrhythmia risk"/>
  <result pre="acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectionJAMA Netw Open32020e208857 69MalviyaA.Ventricular" exact="arrhythmia" post="risk due to chloroquine/hydroxychloroquine treatment for COVID-19: should it"/>
  <result pre="due to chloroquine/hydroxychloroquine treatment for COVID-19: should it be givenIndian" exact="Heart" post="J72202013113232534688 70SimpsonT.F.KovacsR.J.SteckerE.C.Ventricular arrhythmia risk due to hydroxychloroquine-azithromycin treatment for"/>
  <result pre="treatment for COVID-19: should it be givenIndian Heart J72202013113232534688 70SimpsonT.F.KovacsR.J.SteckerE.C.Ventricular" exact="arrhythmia" post="risk due to hydroxychloroquine-azithromycin treatment for COVID-19Eur Heart J92020215221"/>
  <result pre="J72202013113232534688 70SimpsonT.F.KovacsR.J.SteckerE.C.Ventricular arrhythmia risk due to hydroxychloroquine-azithromycin treatment for COVID-19Eur" exact="Heart" post="J92020215221 71CheungC.C.DaviesB.GibbsK.LaksmanZ.W.KrahnA.D.Multi-lead QT screening is necessary for QT measurement:"/>
  <result pre="Cardiol EP62020878880 72MitraR.L.GreensteinS.A.EpsteinL.M.An algorithm for managing QT prolongation in coronavirus" exact="disease" post="2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine"/>
  <result pre="azithromycin: Possible benefits of intravenous lidocaineHeartRhythm Case Rep6202024424832363145 73HeidbuchelH.VerhammeP.AlingsM.Updated European" exact="Heart" post="Rhythm Association Practical Guide on the use of non-vitamin"/>
  <result pre="for cardiac electrophysiology during the coronavirus (COVID-19) pandemic from the" exact="Heart" post="Rhythm Society COVID-19 Task Force; Electrophysiology Section of the"/>
  <result pre="Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the" exact="American" post="College of Cardiology; and the Electrocardiography and Arrhythmias Committee"/>
  <result pre="of the American College of Cardiology; and the Electrocardiography and" exact="Arrhythmias" post="Committee of the Council on Clinical Cardiology, American Heart"/>
  <result pre="Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology," exact="American" post="Heart AssociationHeart Rhythm2020 Apr 1[E-pub ahead of print] 76WaldS.H.ArthoferR.SempleA.K.BhorikA.LuA.C.Determination"/>
  <result pre="and Arrhythmias Committee of the Council on Clinical Cardiology, American" exact="Heart" post="AssociationHeart Rhythm2020 Apr 1[E-pub ahead of print] 76WaldS.H.ArthoferR.SempleA.K.BhorikA.LuA.C.Determination of"/>
 </snippets>
</snippetsTree>
